(Q47191647)

English

Tumor size and T stage correlate independently with recurrence and progression in high-risk non-muscle-invasive bladder cancer patients treated with adjuvant BCG.

scientific article published on 28 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

Tumor size and T stage correlate independently with recurrence and progression in high-risk non-muscle-invasive bladder cancer patients treated with adjuvant BCG. (English)

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

author name string

Ioannis Zachos

1

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

Vasileios Tzortzis

2

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

Lampros Mitrakas

3

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

Michael Samarinas

4

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

Anastasios Karatzas

5

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

Stavros Gravas

6

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

Gerasimos P Vandoros

7

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

Michael D Melekos

8

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

Athanasios G Papavassiliou

9

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

publication date

28 December 2013

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

35

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

4185-4189

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

5

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

https://scigraph.springernature.com/pub.10.1007/s13277-013-1547-8

0 references

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1547-8

21 January 2018

Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and [...]

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1547-8

21 January 2018

Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1547-8

21 January 2018

Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1547-8

21 January 2018

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1547-8

21 January 2018

Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1547-8

21 January 2018

Construction of predictive models for recurrence and progression in >1000 patients with non-muscle-invasive bladder cancer (NMIBC) from a single centre

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1547-8

21 January 2018

Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1547-8

21 January 2018

Low Dose Pasteur Bacillus Calmette-Guerin Regimen in Stage T1, Grade 3 Bladder Cancer Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1547-8

21 January 2018

The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guérin with a reduced dose of 27 mg in superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacillus Calmette-Guérin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder. Four-year results. The Bladder Cancer BCG Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup

1 reference

https://pubmed.ncbi.nlm.nih.gov/24375197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-013-1547-8

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/24375197

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47191647&oldid=1420738558"